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The global burden of disease changes constantly as economic 
developments and health advances influence disease processes 
and human lifestyles. As life expectancy increases, especially in 
developing countries, there is a shift from a burden of acute infectious 
diseases to one of chronic infectious diseases and non-communicable 
diseases (NCDs).[1]
Treatment is becoming more accessible for populations in the 
developing countries, especially treatment of HIV with antiretrovirals 
(ARVs).[1] With reduced mortality, the HIV/tuberculosis (TB) syndemic 
has risen alongside NCDs associated with urbanisation.[2] This rise in 
HIV prevalence has been associated not only with an increased 
incidence of opportunistic infections[3] but also with increased 
risks of developing epilepsy, renal disease, heart disease, chronic 
obstructive pulmonary disease and many other comorbidities.[4] 
South African (SA) studies have also demonstrated that ARVs are an 
independent risk factor for cardiometabolic disease.[5,6]
The rising burden of NCDs has also been linked to increasing 
exposure to environmental and behavioural risk factors.[7] Rapid 
urbanisation has been associated with an increased prevalence of 
type 2 diabetes mellitus in low- to middle-income countries.[4] In 
2012, the Western Cape Mortality Profile in SA showed that the 
five most common causes of death among females were diabetes, 
cerebrovascular disease, ischaemic heart disease, HIV and TB.[8] 
A similar burden of fatal disease was described for men, with 
interpersonal violence replacing diabetes mellitus.[8]
This growing burden of disease has been demonstrated in many 
studies performed at a primary care level, documenting a high 
prevalence of NCDs and extensive multimorbidity in outpatients. 
Barnett et al.[9] describe multimorbidity as the norm among patients, 
a statement with many public health implications. This same 
study found a greater prevalence of multimorbidity in the most 
economically deprived population groups, and at a younger age, than 
in more affluent groups.[9] A recent study[6] performed in an informal 
settlement in Cape Town, SA, confirmed these findings, highlighting 
in particular the frequent comorbidity of hypertension and diabetes 
mellitus. Notably, comorbidity associations were found not only 
between diseases of lifestyle, but also between infectious diseases 
such as TB and various NCDs.[6] Mental illness is also associated 
with chronic disease, both infectious and non-infectious, and is 
particularly prevalent in those suffering from HIV and TB.[1,2] Mental 
illness contributes to the patient’s burden of multimorbidity, but also 
specifically affects quality of life and treatment outcomes.
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Background. There is substantial research documenting the burden of disease globally and in the South African (SA) primary care context. 
Few studies address the disease profile and its implications in the SA hospital setting.
Objectives. To describe the disease profile in the internal medicine department of a large district hospital, using variables related to 
comorbidity and patient length of stay. The study included specific exploration into the HIV/tuberculosis (TB) syndemic, the acuity of HIV 
disease, and lifestyle risk factors.
Methods. The sample population consisted of all consecutive admissions to the internal medicine department of a large district hospital in 
the Cape metropole during May 2015. A retrospective folder review and subsequent data analysis were completed.
Results. Hypertension, HIV, type 2 diabetes mellitus, TB and cardiac failure were the five most prevalent diseases. Extensive multimorbidity 
was observed, with 86.0% of patients suffering from two or more diseases concurrently. The average number of comorbidities per patient 
was 3.4, although no clear relationship between the number of comorbidities and length of stay was found. Of the various diseases, only 
TB and HIV were associated with above-average length of stay, particularly among co-infected patients and those who had defaulted from 
or never received antiretroviral (ARV) treatment. Compared with patients currently receiving ARVs, much higher proportions of patients 
who had defaulted from or never received ARV treatment had CD4+ counts <200 cells/µL. Of the lifestyle risk factors investigated, a history 
of excessive alcohol use and/or drug use was associated with an increased length of stay. Most patients were discharged home, with 15.7% 
being referred to other institutions.
Conclusions. Chronic conditions, particularly HIV, TB and non-communicable diseases, represented much of the disease profile in the 
internal medicine department. Of the comorbidities investigated, the greatest contributor to length of stay was HIV/TB co-infection. 
Factors such as HIV, TB and substance use that increase length of stay cannot be impacted upon by the district hospital staff in isolation. To 
improve the health of communities, we require partnerships between doctors, community health providers and patients with their families. 
Multimorbidity was widespread, suggesting the need to include an understanding of multimorbidity, including the patient perspective, in 
medical education and health system reform.
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Despite extensive analysis of morbidity patterns at a population and 
primary care level, there is limited research into the disease profile at 
a district level of care in SA. Understanding multimorbidity in each 
healthcare context is essential, as patients with comorbid conditions 
are particularly vulnerable to suboptimal care.[10] Multimorbidity in 
itself is an independent predictor of treatment complications and 
poor quality of life, and must therefore be thoroughly understood 
when making both clinical and institutional health decisions.[10]
Objectives
By investigating the disease profile at a district-level hospital, to add 
to the existing knowledge and understanding of multimorbidity in 
SA. In addition, the study aimed to specifically explore the HIV/TB 
syndemic, the acuity of HIV disease, lifestyle risk factors and patient 
length of stay.
Methods
Ethics approval was obtained from the Human Research Ethics 
Committee of the University of Cape Town (ref. no. 423/2015). 
This was a retrospective folder review. Admissions to the internal 
medicine department at a large district hospital in Cape Town were 
sampled, using consecutive admissions for the month of May 2015. 
Non-discharged and deceased patients were excluded, owing to 
inaccessibility of their folders. Each patient’s folder number, age, date 
of birth, gender, triage details, comorbidities, lifestyle risk factors, 
length of stay and discharge destination were recorded.
Triage values consisted of each patient’s triage code, determined 
by clinical discriminators that indicate acuity upon admission as per 
the South African Triage Score.[11] A history of cigarette smoking, 
excessive alcohol use and drug use were the three lifestyle factors 
recorded. Length of stay was calculated in units of 24 hours. The 
discharge destination was either home or the referral institution. The 
CD4+ counts for HIV-positive patients were also recorded.
Statistical analysis
The data were analysed using Microsoft Excel, 2011 version (Micro-
soft, USA). The 10 most prevalent diseases and the prevalences of 
the various lifestyle risk factors were calculated. These diseases and 
lifestyle risk factors were then described in relation to patient length 
of stay and number of comorbidities, with a focus on HIV-positive 
patients and HIV/TB co-infected patients.
Results
Sample population
The sample population consisted of 491 patients from the internal 
medicine department, of whom 8.8% were readmitted and discharged 
during the same month. Of the patients, 57.4% were female and 
42.6% male, with a mean age of 49.0 years (Table 1).
Triage
Of the patients, 38/491 (7.7%) were coded green on admission, 130 
(26.5%) yellow, 231 (47.0%) orange and 51 (10.4%) red (the triage 
code was not documented for 41 patients). The most common triage 
code was therefore orange, with red and orange codes constituting 
>50% of admissions.
Prevalence of various diseases and lifestyle risk factors
Hypertension (40.9%), HIV (29.7%) and type 2 diabetes mellitus 
(25.9%) were the three most prevalent diseases, followed by current 
TB and cardiac failure (Table 2). HIV/TB co-infection was found 
in 17.1% of admissions. Mental illnesses counted as individual 
diagnoses, i.e. depression, bipolar mood disorder, anxiety disorder 
and schizophrenia, affected six or fewer patients each, but in the 
group as a whole, 6.3% of patients had mental illness.
When investigating the subcategories of TB patients, it was found 
that 66.7% suffered from pulmonary TB, the second and third most 
common forms being disseminated TB (16.7%) and multidrug-
resistant TB (10.2%).
Patient length of stay
The average length of stay for all patients was 6.0 days. More than 
two-thirds of patients stayed for ≤6 days, and the distribution of 
length-of-stay values showed that the mode was 3 days.
Table 1. Characteristics of study participants 
Category
Patients/folders
Patients in May discharge list, N 526
Unavailable patient folders, n 35
Total accessible folders, n 491
Readmissions, n (%)* 43 (8.8)
Gender, n (%)*
Female 282 (57.4)
Male 209 (42.6)
Age (years)
Mean (range) 49.0 (13 - 88)
SD 17.7
Median (IQR) 49.0 (33.0 - 62.5)
SD = standard deviation; IQR = interquartile range.
*% of accessible folders.
Table 2. Prevalence of various diseases* (N=491)
Diagnosis n (%)
Hypertension 201 (40.9)
HIV infection 146 (29.7)
Type 2 diabetes mellitus 127 (25.9)
Current TB 108 (22.0)
Cardiac failure 75 (15.3)
Pneumonia 72 (14.7)
Renal failure (acute and chronic) 67 (13.7)
COPD 65 (13.2)
Ischaemic heart disease 62 (12.6)
Asthma 53 (10.8)
Lower respiratory tract infection 43 (8.8)
Dyslipidaemia 39 (7.9)
Gastroenteritis 38 (7.7)
Cerebrovascular accident 34 (6.9)
Epilepsy 32 (6.5)
Anaemia 28 (5.7)
Sepsis 21 (4.3)
Cancer 20 (4.1)
Urinary tract infection 20 (4.1)
Delirium 17 (3.5)
Cor pulmonale 15 (3.1)
Deep vein thrombosis 14 (2.9)
Bronchiectasis 13 (2.6)
Dilated cardiomyopathy 11 (2.2)
TB = tuberculosis; COPD = chronic obstructive pulmonary disease.
*Excluded if prevalence ≤2%.
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Looking at the 10 most prevalent diseases, patients with current TB 
were found to have the greatest average length of stay (7.5 days), 
followed by HIV-positive patients (6.9 days). Patients with HIV/TB 
co-infection had an even greater average length of stay (7.7 days). No 
one of the remaining eight most prevalent diseases was associated 
with an average length of stay greater than that of the sample 
population.
Patients with HIV/TB co-infection were also found to have the 
highest proportion of individuals with an increased length of stay, with 
39.3% of these patients staying >8 days (the 3rd quartile) (Fig. 1). An 
increased length of stay was also seen in >25% of patients with TB, HIV 
infection, renal failure and pneumonia (Fig. 1).
Comorbidities of patients
Of the patients, 427 suffered from more than one disease concurrently, 
putting the prevalence of multimorbidity at 87.0%. The maximum 
number of confirmed diagnoses was 9 and the minimum was 1, with 
a mode of 3 comorbidities. The average number of comorbidities for 
the sample population was 3.3.
The highest number of comorbidities was found in patients 
with ischaemic heart disease, with an average of 4.8 concurrent 
diseases. Average length of stay was not associated with number of 
comorbidities, and for patients with a length of stay greater than 
the third quartile (length of stay ≥8 days), the average number 
of comorbidities was also 3.3, no greater than that of the sample 
population.
Contribution of HIV
Investigation of the treatment status of HIV-positive patients showed 
that 44.5% of these patients were using ARVs during their hospital 
stay, 16.4% had defaulted from their ARV treatment before admission, 
and 39.0% were ARV naive upon admission.
Of the 146 HIV-positive patients, 88.4% had recorded CD4+ 
counts. The average CD4+ count was 218.3 cells/µL, with 62.8% 
of patients having a very low CD4+ count (<200 cells/µL). The 
proportion of patients with a very low CD4+ count was highest 
among those who had defaulted from ARV treatment (77.3%), 
followed by those who had never received ARV treatment (70.8%) 
and then those currently using ARVs (52.6%) (Fig. 2).
Although CD4+ count was not directly associated with length 
of stay, average length of stay was found to be associated with ARV 
treatment status. Patients who had defaulted from ARV treatment 
had an average length of stay of 8.3 days, 2.5 days more than the 
average length of stay of patients using ARVs (Fig. 3).
Contribution of lifestyle risk factors
The most prevalent lifestyle risk factor was found to be cigarette 
smoking, with 34.8% of patients reporting a history of smoking, 
16.7% excessive alcohol use and 7.7% drug use. Methamphetamines 
were the drugs most commonly used by these patients (46.3%), 
followed by marijuana (31.7%), mandrax (26.8%) and heroin (4.9%).
Investigation of the association between lifestyle risk factors and 
average length of stay showed that of the three lifestyle risk factors, 
drug abuse and excessive alcohol use were associated with an average 
length of stay greater than that of the sample population (7.7 days and 
6.9 days, respectively) (Fig. 4). No significant association was shown 
between lifestyle risk factors and number of comorbidities.
Discharge information
Of the patients, 84.3% were discharged home. The remaining patients 
were referred to a level 2/3 hospital (6.7%), to a rehabilitation or 
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Fig. 1. Proportion of patients with length of stay ≥8 days, comparing the 
10 most prevalent diseases. (TB = tuberculosis; COPD = chronic obstructive 
pulmonary disease.)
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Fig. 2. CD4+ counts above and below 200 cells/µL, according to ARV treat­
ment status. (ARV = antiretroviral.)
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Fig. 3. Average length of stay of HIV­positive patients according to treatment 
status.
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intermediate-care facility (4.7%) or to a specialised TB hospital 
(3.7%).
Discussion
This study investigated the disease profile in the internal medicine 
department at a large district hospital in the Cape metropole during 
May 2015. This is a specific subset of the patient population that has 
decompensated to the extent of requiring admission to the hospital. 
While this study describes admissions to a district hospital, these 
need to be seen as part of the continuum of care[12] from community-
based care and primary care through to referral to central hospitals. 
The clinical pressures of work may discourage busy doctors from 
thinking outside of the walls of the hospital, but it is important to 
have a health system perspective and consider ways of encouraging 
healthy behaviour after discharge. This is often left to primary care 
providers, despite hospital admission being an important opportunity 
for intervention. Training in brief behaviour change counselling on 
NCD lifestyle risk factors[13] can improve the skills of both hospital 
and primary care doctors.
As expected, extensive comorbidity was observed throughout the 
sample population, with a high prevalence of both non-communicable 
and chronic infectious diseases. The results indicated that patients 
with HIV/TB co-infection or untreated HIV, those who had defaulted 
from ARV treatment, and those with a positive history of drug or 
excessive alcohol use in particular had an increased length of stay.
Acuity of medical admissions
Medical admissions were most frequently classified as urgent or very 
urgent, with more than half of the patients being classified as orange 
or red on admission according to the South African Triage Score.[11]
Length of stay
The average length of stay for all patients in the sample population 
was 6.0 days. This number is high compared with other district 
hospitals in SA, where the 2013/14 average length of stay in district 
hospitals was found to be 4.7 days nationally and 3.7 days in the 
Western Cape Province.[14] According to departmental guidelines, 
a raised average length of stay may be linked to the decreased 
availability of hospital staff to oversee patient discharges.[14] Delayed 
referral may also contribute to delayed discharge, suggesting that 
future research should incorporate data from the associated referral 
facilities. In the context of extensive multimorbidity, it is clear that 
patients may require multiple sites of care with an increased reliance 
on referral efficiency, making a well-connected multiprofessional 
team an important requirement for rapid patient turnover.[10]
In terms of the distribution of length of stay values, patients with 
HIV, TB or HIV/TB co-infection were the only ones with an average 
length of stay greater than that of the sample population. More than 
a third of these patients had a hospital stay of >8 days. A previous 
study at G F Jooste Hospital in Cape Town found an average length 
of stay of 9.6 days for inpatients with HIV.[3] This suggests that 
although processes for generally improving patient turnover should 
be investigated, research can also be focused specifically on reducing 
in-hospital time of HIV, TB and co-infected patients, as well as 
avoiding admission by improving early diagnosis and treatment of 
HIV as outlined in the Joint United Nations Programme on HIV and 
AIDS (UNAIDS) 90-90-90 strategy.[15]
Average length of stay was also associated with various lifestyle 
factors. Both excessive alcohol use and drug use were associated 
with an average length of stay greater than the average for the 
sample population (Fig. 4). Doctors can play a role by providing 
brief behaviour change counselling[13] and referring patients to 
community-based rehabilitation services.
Multimorbidity
The five most prevalent diseases were found to be hypertension, 
HIV, type 2 diabetes mellitus, TB and cardiac failure (Table 2), with 
HIV/TB co-infection in 17.1% of patients. Multimorbidity was 
recorded in 86.0% of patients and increased with patient age. These 
findings are consistent with various SA multimorbidity studies 
performed at a population and primary care level, suggesting that 
multimorbidity is an expected norm among patients at multiple 
levels of healthcare.[6,16,17] This has vast implications for healthcare 
provision. Drug trials should be conducted with the knowledge of 
the most likely comorbidities and related treatments,[10] medical 
education should teach an integrated approach instead of discussing 
diseases separately,[9] and health professionals should be aware of the 
complexity of the challenges faced by a patient living with multiple 
comorbid conditions.[6]
This concept has been described by Shippee et al.,[18] who developed 
a patient-centred model of patient complexity. This model proposes 
that treatment adherence, healthcare utilisation and health outcomes 
are influenced by the relationship between the workload that is 
delegated to patients by healthcare providers (including managing 
self-care, treatment modalities, behaviour change and clinic visits), 
and patients’ capacity to meet the demands of this workload (including 
physical and mental functioning, pre-existing health literacy and 
family and social support). In the Shippee model, multimorbidity 
is likely to both increase workload and reduce capacity – over time 
it adds complexity to patient experiences, and leads to ineffective 
and inappropriate outcomes.[19] This model can assist doctors to 
be less judgemental and more patient centred when patients with 
multimorbidity find it difficult to adhere to treatment.
When patients are discharged, doctors are not always aware of their 
capacity to do what is expected of them. It is helpful to speak to the 
families when patients are discharged, as well as to refer to community-
based services. The importance of a good referral letter needs to be 
emphasised. When completed in full and with attention to detail, this 
can be an important tool in ensuring continuity of care.[12]
Interestingly, despite this issue of increasing complexity and poorer 
outcomes, we did not find multimorbidity to be associated with an 
increased length of stay in hospital. Patients with multiple diseases 
may have more complex management and require more resources 
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Fig. 4. Association between lifestyle risk factors and average length of stay.
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while in hospital, but patients with comorbid conditions do not 
necessarily require care in the internal medicine wards for a longer 
period of time than those without.
Comorbidity was also not associated with any specific disease. 
Although ischaemic heart disease was associated with the greatest 
number of comorbidities, there was very limited variation across 
diseases. This suggests that other factors play a role in multimorbidity. 
In terms of the lifestyle risk factors investigated in this study, no 
significant relationship was found between any of the three lifestyle 
risk factors and number of comorbidities, despite previous research 
showing that smoking is a risk factor for multimorbidity.[16]
Other SA studies have described the role of socioeconomic 
factors in determining the extent of multimorbidity, suggesting that 
economic factors such as unemployment may underlie and lead to 
multimorbidity.[16] The burden of multimorbidity is generally higher 
in the poor, who often have a reduced capacity to deal with ill health.[19]
Over 6% of patients in the internal medicine department had a 
recorded mental illness, highlighting the need for mental health 
support in wards that are not primarily for psychiatric care. Mental 
health issues are associated with chronic disease[2] – HIV and 
TB specifically[1] – suggesting that there may be patients with 
undiagnosed mental health issues in the sample population, which is 
taken from a department with a high prevalence of both NCDs and 
chronic infectious diseases. This is supported by a recent study in the 
Western Cape, where >50% of patients with hypertension, chronic 
respiratory disease or diabetes mellitus showed signs of depression.[17] 
Doctors should be aware of the high prevalence of comorbid mental 
health issues in patients with chronic diseases and how mental health 
issues may affect a patient’s response to treatment. Mental health 
screening should be implemented in consultations for patients with 
chronic illnesses to encourage early intervention.
The contribution of HIV
Of the patients admitted to the internal medicine department, 29.7% 
were diagnosed with HIV, either before admission or during their 
hospital stay. Less than half of these patients were currently using 
ARVs, an indication of the many challenges faced by national efforts 
to upscale HIV treatment over the past 10 years.[20]
Treatment stage was significantly associated with CD4+ count. 
Less than half of the patients using ARVs were classified as having 
a very low CD4+ count (<200 cells/µL), whereas >70% of patients 
who had defaulted from ARV treatment were classified as having a 
very low CD4+ count (Fig. 2). Treatment stage also had significant 
implications for the burden of disease; patients on ARVs did not 
have a greater average length of stay than the sample population as 
a whole, but patients who had defaulted from treatment stayed on 
average 2.5 days longer than those on treatment, and patients who 
were ARV naive stayed for 1.8 days longer than those on treatment. 
This highlights the ongoing need for an effective HIV counselling 
and treatment programme at primary care level, a challenge that is 
still faced after aggressive government interventions over the past 
decade.[20] While the patient is in hospital, adherence counselling can 
be helpful to try to prevent future admissions, as well as encouraging 
patients to go to their local ARV clinic after discharge.
Study limitations and strengths
This study had a number of limitations. The methodology involved 
folder review by multiple students, possibly leading to discrepancy 
in the recording of variables. Reliance on clinical records may have 
led to incorrect interpretation of doctors’ handwritten notes, and 
no other sources were available to ensure that all handwritten notes 
were recorded correctly and completely. With regard to lifestyle risk 
factors, it is likely that the information provided by the patients was 
strongly affected by social stigma, particularly in the case of illicit 
drug use, resulting in under-reporting of these risk factors.
Selection bias was present owing to exclusion of patients who were 
discharged after the end of the month of May, as well as exclusion 
of those recorded as deceased, because of inaccessibility of folders. 
Although the majority of patient folders were found on the hospital’s 
intranet database, 35 folders were inaccessible. The population sample 
included only one month of admissions from a single department at a 
district hospital, so the results cannot be generalised to other hospital 
departments or to other districts in SA. Owing to the cross-sectional 
nature of the study, no causative associations can be drawn between 
lifestyle factors and comorbidities, or between various comorbidities.
Strengths include the large sample size (N=491) and the use of 
primary sources of patient information. Access to clinical records 
meant that there was no reliance on self-reporting of medical 
conditions.
Conclusions
This study described multimorbidity and factors contributing to 
the length of stay of patients in a district hospital. Multimorbidity 
was found to be the norm among patients, which should encourage 
healthcare professionals to shift from the view of a single diagnosis 
with comorbidities, to a single case of multimorbidity.
Multimorbidity has several facets, including biological interactions 
between diseases, risk factors and treatments; patient perspectives; 
health worker perspectives; and implications for health systems. [19] 
An understanding of the patient perspective can be beneficial, 
where according to Shippee’s model[18] patient workload and capacity 
interact to affect healthcare utilisation and health outcomes.
An increased length of stay was found to be associated with HIV 
and/or TB diagnosis, non-adherence to ARV treatment or ARV 
naivety, and alcohol and drug use. This is a reflection of health 
challenges at a community and primary level of care, and these factors 
cannot be impacted upon by the district hospital staff in isolation. To 
improve the health of communities, we require partnerships between 
doctors, community health providers and patients with their families. 
Good communication is essential between levels of care.
The study findings have significant research implications. An 
understanding of multimorbidity can be used when designing 
medical education programmes, clinical drug trials and treatment 
regimens as well as when reforming health systems.
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